تخطي إلى التنقل الرئيسي
تخطي إلى البحث
تخطي إلى المحتوى الرئيسي
الصفحة الرئيسية
المساعدة والأسئلة الشائعة
English
العربية
الصفحة الرئيسية
الوحدات البحثية
الملفات الشخصية
نتاج البحث
المشاريع
المعدات
أنشطة
مجموعات البيانات
الصحافة / وسائل الإعلام
الجوائز
التأثيرات
الدورات التدريبية
البحث حسب الخبرة أو الاسم أو الانتماء
Effect of Prolactin receptor antagonist in treatment of ovarian cancer
Al Kharusi, Amira
(PI)
Medicine And Health Sciences
المشروع
:
Other project
معاينة
بصمة
بصمة
استكشف موضوعات البحث التي تناولها هذا المشروع. يتم إنشاء هذه الملصقات بناءً على الجوائز/المنح الأساسية. فهما يشكلان معًا بصمة فريدة.
فرز حسب
الوزن
أبجديًا
Keyphrases
Ovarian Cancer
100%
Prolactin Receptor Antagonist
100%
Tumor
71%
Cytomegalovirus
71%
Growth Factors
57%
Ovarian Tumor
42%
Hormone-sensitive
42%
Cancer Treatment
28%
Prostate Cancer
28%
Hormone-responsive
28%
Tumor Survival
28%
Extrapituitary
28%
Single-point mutation
28%
Breast Cancer
28%
Regulatory Cells
28%
Cancer Types
28%
Receptor Density
28%
Latent Viral Infection
28%
Tumor Growth
28%
Growth Signaling
28%
Prolactin Level
28%
Tumorigenesis
28%
Local Production
28%
Cell Signaling
28%
Prolactin
28%
Viral
28%
Ovarian Cancer Risk
28%
Prostate
28%
Hormone Action
28%
Host Genome
28%
Cell-based Assay
28%
Sweden
28%
Pituitary
14%
Tissue Survival
14%
JAK-STAT Pathway
14%
Role in Cancer
14%
Brain Tumor
14%
Abdomen
14%
Cell Surface Receptor
14%
Tumor Cells
14%
Tissue Susceptibility
14%
Breast
14%
Malignant Phenotype
14%
Tuberous Sclerosis Complex
14%
Angiogenesis
14%
Pituitary Tissue
14%
Ovarian Cells
14%
Human Cancer
14%
Obese Women
14%
Ovarian Carcinogenesis
14%
Pelvis
14%
Homodimer
14%
Ovarian Carcinoma
14%
Most Common Form
14%
Prognostic Score
14%
Pathway Activation
14%
MTOR Pathway
14%
Gynecologic Malignancy
14%
Mammary Gland
14%
Strong Families
14%
Binding Site
14%
Non-coding RNA (ncRNA)
14%
Neuroblastoma Tumor
14%
Malignant Ovarian Tumor
14%
Human Malignancies
14%
Mutation Sites
14%
Arginine
14%
Success Strategies
14%
Human Cytomegalovirus
14%
Human Cytomegalovirus Infection
14%
Helix
14%
Cytokine Production
14%
SOCS2
14%
Condition Control
14%
Molecular Pathways
14%
Antigrowth
14%
Prolactin Receptor
14%
Salivary Gland Tumor
14%
Regulatory Proteins
14%
Ovarian Epithelial Cancer
14%
Glycine
14%
Healthy Controls
14%
Locally Produced
14%
Genetic mutation
14%
Cancer Hallmarks
14%
Lymphocytes
14%
Extraovarian
14%
Dopamine Receptor Agonist
14%
Malignant Tumor
14%
Ovarian Cancer Cells
14%
Receptor Expression
14%
New Therapeutics
14%
Tumor Spread
14%
Antiviral Treatment
14%
Cancer Causes
14%
Pituitary Gland
14%
Delayed Diagnosis
14%
Anticancer Agents
14%
Tumor Development
14%
High Mortality Rate
14%
Family History
14%
Hepatocellular Cancer
14%
Benign Conditions
14%
Angels
14%
Female Genital
14%
Viral Infection
14%
Tight Control
14%
Cell Properties
14%
Receptor Binding
14%
Apoptotic Mechanism
14%
Cell number
14%
Colon
14%
Receptor Dimerization
14%
Dimer Molecules
14%
Women of Reproductive Age
14%
Cytomegalovirus Infection
14%
Intracellular Signaling
14%
Genital Cancer
14%
Rhabdomyosarcoma
14%
Chemical Exposure
14%
Clinical Application
14%
Tissue Sampling
14%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor Antagonist
100%
Ovary Cancer
100%
Malignant Neoplasm
100%
Prolactin Receptor
100%
Neoplasm
69%
Receptor
53%
Prolactin
46%
Cytomegalovirus
38%
Ovary Tumor
30%
Growth Factor
30%
Carcinogenesis
23%
Virus Infection
23%
Tumor Growth
15%
Cytomegalovirus Infection
15%
Breast Cancer
15%
Prostate Cancer
15%
Platelet Derived Growth Factor
15%
Human Cytomegalovirus
15%
Epithelium Tumor
7%
Salivary Gland Tumor
7%
Brain Tumor
7%
Arginine
7%
Ovary Carcinoma
7%
Neuroblastoma
7%
Metastasis
7%
Cytokine
7%
Suppressor of Cytokine Signaling 2
7%
Binding Site
7%
Tuberin
7%
Mortality Rate
7%
Infection
7%
Homodimer
7%
Obesity
7%
Dimer
7%
Dopamine Receptor Stimulating Agent
7%
Rhabdomyosarcoma
7%
Regulator Protein
7%
Female Genital Tract Cancer
7%
Antivirus Agent
7%
Anticarcinogen
7%
Untranslated RNA
7%
Cell Surface Receptor
7%
INIS
prolactin
100%
receptors
100%
ovaries
100%
cancer
100%
tumors
69%
hormones
42%
production
38%
signals
34%
prostate
15%
growth factors
15%
humans
15%
levels
15%
growth
15%
tissues
15%
control
15%
sensitivity
15%
women
15%
breasts
11%
mutations
11%
proliferation
11%
affinity
11%
houses
7%
in vivo
7%
malignancies
7%
proteins
7%
sweden
7%
drugs
7%
risks
7%
investigations
7%
patients
7%
host
7%